SCHEMBL14100950

SCHEMBL14100950

c1ccc(Oc2c3ccccc3c(-c3c4ccccc4nc4ccccc34)c3ccccc23)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.78
KDM4E B2RXH2 2/20 0.78
GLA P06280 2/20 0.78
KMT2A Q03164 1/20 0.78
KDM1A O60341 1/20 0.61
HTT P42858 2/20 0.47
LMNA P02545 2/20 0.47
POLB P06746 2/20 0.47
ABCG2 Q9UNQ0 1/20 0.46
ESR1 P03372 2/20 0.44
ESR2 Q92731 2/20 0.44
TOP2A P11388 3/20 0.44
TOP2B Q02880 3/20 0.44
RAB9A P51151 2/20 0.44
ALDH1A1 P00352 4/20 0.42
MAOA P21397 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CHRM2 P08172 1/20 0.42
ADRA2A P08913 1/20 0.42
ADORA3 P0DMS8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL455804 0.88 KDM4E (1.00) MAPTKDM4EGLAKMT2AKDM1A
SCHEMBL30003990 0.81 KDM4E (0.70) MAPTKDM4EGLAKMT2AKDM1A
SCHEMBL4898172 0.81 KDM4E (0.70) MAPTKDM4EGLAKMT2AKDM1A
SCHEMBL1502392 0.78 ALDH1A1 (0.62) MAPTKDM4EGLAKMT2AKDM1A
SCHEMBL14100900 0.78 KDM4E (0.55) MAPTKDM4EGLAKMT2AKDM1A
SCHEMBL14100961 0.77 KDM4E (0.56) MAPTKDM4EGLAKMT2AKDM1A
SCHEMBL17423220 0.77 KDM4E (0.78) MAPTKDM4EGLAKMT2AKDM1A
SCHEMBL14100955 0.77 MAPT (0.55) MAPTKDM4EGLAKMT2AKDM1A
SCHEMBL14100949 0.76 MAPT (0.54) MAPTKDM4EGLAKMT2AKDM1A
SCHEMBL13400206 0.76 ALDH1A1 (0.59) MAPTKDM4EGLAKMT2AKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080166593-A1 Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-07-10 US disclosed
US-20080166593-A1 Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166593-A1 Organic Electroluminescent Devices OR10J3, DDT, EML4 MAPT 882/4885KDM4E 1218/4885GLA 2936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.